President of EFORT Ass. Prof. Dr Per Kjaersgaard-Andersen welcomes delegates to the 20th EFORT annual congress 2019, taking place from
5-7 June 2019, in Lisbon, Portugal
The most important aim of joint arthroplasty is to find the best solution not only for the patient, but also for both the implant and the bearings to make the “new joint” work perfectly for the rest of the patient’s life. Science, research and especially long-term national registry investigations have all given good guidance on when the risk of joint arthroplasty failure is higher compared to other implants and/or situations. Therefore, the use of registry data from research to education purposes is key to provide advice and awareness, experiences and practices in medical device surveillance and arthroplasty outcomes to improve patient care.
On an international perspective, the EFORT annual meetings can serve as a platform to disseminate education and research on registry data, not only to our national members, but also to the public and government bodies, and to industry partners related to the development of medical devices. This enhances patient, public confidence and trust in medical devices and surgeons who use them, in order to sustain and improve public health.
A European platform to be able to learn other countries’ practices in regards to the use of registries allows the Orthopaedics & Traumatology (O&T) community to have an early awareness system, combining the information of several databases with thousands of entries. By creating a network to talk about best practice and how registries are organised in different parts of Europe, this approach makes a real difference, allowing surgeons to learn from each other and improve their skills by seeing data, which otherwise could not be available to them.
It is for this reason that, “Registries & Impact On Practice” has been chosen as the main theme of 20th EFORT Congress in Lisbon. The highlights under this overarching theme will include patient selection, implant selection and survival, prediction of outcome, value-based healthcare, revision rate, patient safety, quality improvement, patient-reported outcome and patient involvement.
Advocating for a better quality of life and working with the European Orthopaedic and Traumatology community for the delivery of high-end musculoskeletal healthcare for European population are the basis of EFORT’s mission. We believe that the 2019 Congress main theme is very much aligned with our mission, which will bridge important components within the scientific programme. As a delegate you will also have the chance to see the latest products related to joint arthroplasty from our industry partners in the exhibition area.
View the programme online at https://congress.efort.org. It is my pleasure to invite you to join us for what promises to be an outstanding scientific congress in Lisbon, a city considered as a symbol of the will of discovery.
We hope the 2019 EFORT Congress destination will be as enjoyable and entertaining as it is expected to be educationally rewarding.
5-7 June 2019
20th EFORT Congress
Venue: Lisbon
